7th Complement Drug Development Hilton Boston Logan Airport, Boston

Returning for its 7th year, the Complement-Based Drug Development Summit evaluates the entirety of the complement landscape, from scientific understanding to strategic, commercial intelligence.

This summit returns in a timely fashion to delve into the expanding therapeutic opportunities: from understanding the degree of complement inhibition needed, to mitigating toxicity effects with targeted approaches, hear how clinical scientists are optimizing clinical development by uncovering predictive biomarkers better informing patient populations, interpreting results, and strategizing regulatory approval across ophthalmology, neurology, haematology, and nephrology.

New for 2023, a full pre-conference workshop composed of 4 deep diving discursive sessions split into a preclinical and clinical stream, both dedicated to overcoming the bottlenecks, and progressing development no matter what stage your pipeline is.

Network with 150+ of your industry colleagues from around the globe, join the largest community of complement-based drug development experts to build meaningful connections and gather insights beyond the literature.